ID   Nur-1
AC   CVCL_1Q60
DR   Wikidata; Q54931178
RX   PubMed=25627346;
CC   Population: Japanese.
CC   Doubling time: 6.1 days (Note=At 30th passage), 5.8 days (Note=At 60th passage), 5.6 days (Note=At 103th passage) (PubMed=25627346).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
RX   PubMed=25627346; DOI=10.1007/s13577-014-0108-9;
RA   Ohyama, Akihiro
RA   Nikaido, Takashi
RA   Tachibana, Toshiaki
RA   Tominaga, Noriko
RA   Toyomura, Junko
RA   Kimura, Eizo
RA   Nakahara, Taka
RA   Yasuda, Makoto
RA   Ishikawa, Hiroshi
RT   "Establishment and characterization of a cell line designated Nur-1
RT   derived from human endometrioid adenocarcinoma of uterine corps.";
RL   Hum. Cell 28:100-107(2015).
//